文献速递肝病

VA初级保健人群中NAFLD与MAFLD的患病率、决定因素及其严重程度

The Prevalence and Determinants of NAFLD and MAFLD and Their Severity in the VA Primary Care Setting.
PubMed 文献 · Clin Gastroenterol Hepatol · 2022-07-08

在休斯顿VA初级保健机构随机抽取患者进行横断面研究,NAFLD患病率为40.6%(82/202),所有NAFLD患者均符合MAFLD标准(100%一致)。与无代谢特征者相比,具有≥3项代谢特征者NAFLD/MAFLD风险 adjusted OR 为47.6(95%CI 11.3-200)。9.4%的参与者存在至少中度肝纤维化。

要点

  • NAFLD患病率为40.6%(82/202),与MAFLD定义完全一致(100%)。
  • ≥3项代谢特征者较无代谢特征者NAFLD/MAFLD风险 adjusted OR 47.6(95%CI 11.3-200)。
  • 9.4%的参与者存在至少中度肝纤维化,其中多数合并NAFLD。

核心结论

  • VA初级保健人群中NAFLD患病率为40%,9.4%的退伍军人存在至少中度肝纤维化,且多数合并NAFLD。
  • NAFLD与MAFLD替代定义之间完全一致。

研究设计与样本

  • 在休斯顿退伍军人事务(VA)机构初级保健中随机选取患者进行的横断面研究。
  • 参与者完成调查、提供血液样本并接受Fibroscan检查。
  • 在无大量饮酒、丙型肝炎病毒和乙型肝炎病毒的情况下,以受控衰减参数中位数≥290 dB/m定义NAFLD;MAFLD定义为受控衰减参数中位数≥290 dB/m且满足以下任一条件:体重指数≥25 kg/m2或糖尿病,或以下2项及以上:高血压、高甘油三酯、低高密度脂蛋白胆固醇、高高密度脂蛋白胆固醇。

主要发现

  • 参与者平均年龄50.9岁,55.4%为女性,42.8%为白人,43.8%为黑人。
  • NAFLD患病率为40.6%(82/202)。
  • 所有82例NAFLD患者体重指数均≥25 kg/m2,因此均符合MAFLD标准(即100%一致)。
  • 与无代谢特征者相比,具有≥3项代谢特征者NAFLD/MAFLD风险 adjusted OR 为47.6(95%CI 11.3-200)。
  • 总体19例参与者(占总人数9.4%,占NAFLD患者的15.9%)存在至少中度纤维化。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: A recent panel of international experts proposed the disease acronym metabolic (dysfunction)-associated fatty liver disease (MAFLD) in lieu of nonalcoholic fatty liver disease (NAFLD). We aimed to estimate the burden of and risk factors for NAFLD and MAFLD, and to examine the concordance between definitions in a Veterans population. METHODS: We conducted a cross-sectional study among randomly selected patients within primary care at the Houston Veterans Affairs (VA) facility. Participants completed a survey, provided blood, and underwent Fibroscan. In the absence of heavy alcohol, hepatitis C virus and hepatitis B virus, a controlled attenuation parameter median ≥290 dB/m was used to define NAFLD, whereas MAFLD was defined as controlled attenuation parameter median ≥290 dB/m and either body mass index ≥25 kg/m2 or diabetes, or 2 or more of the following: hypertension, high triglycerides, low high-density lipoprotein cholesterol, and high low-density lipoprotein cholesterol. RESULTS: The mean age of participants was 50.9 years, 55.4% were women, 42.8% were white, and 43.8% were Black. The prevalence of NAFLD was 40.6% (82/202). All 82 patients with NAFLD had a body mass index ≥25 kg/m2, and therefore met our criteria for MAFLD (ie, 100% concordance). Compared with patients with no metabolic trait, patients with ≥3 traits had a 48-fold (adjusted odds ratio, 47.6; 95% confidence interval, 11.3-200) higher risk of NAFLD/MAFLD. Overall, 19 participants (9.4% of the total, 15.9% of those with NAFLD) had at least moderate fibrosis. CONCLUSIONS: NAFLD was present in 40% of Veterans registered in primary care; 9.4% of veterans had at least moderate hepatic fibrosis, with most having concurrent NAFLD. There was perfect concordance between NAFLD and the alternative MAFLD definition.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Thrift AP, Nguyen TH, Pham C, et al. The Prevalence and Determinants of NAFLD and MAFLD and Their Severity in the VA Primary Care Setting. Clin Gastroenterol Hepatol. 2022. PMID: 35811043. doi:10.1016/j.cgh.2022.05.046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。